Ts-1



Combined with:

Indications and Reactions:

Role Indications Reactions
Primary
Gastric Cancer 100.0%
Refusal Of Treatment By Relative 100.0%
Secondary
Gastric Cancer 24.2%
Colon Cancer 7.3%
Hypertension 6.2%
Drug Use For Unknown Indication 5.9%
Non-small Cell Lung Cancer 5.9%
Cancer Pain 5.7%
Pain 5.7%
Prophylaxis 5.2%
Constipation 4.5%
Product Used For Unknown Indication 4.3%
Premedication 3.2%
Insomnia 3.2%
Nausea 3.1%
Metastatic Gastric Cancer 2.7%
Colon Cancer Metastatic 2.6%
Antiemetic Supportive Care 2.4%
Large Intestine Carcinoma 2.3%
Prophylaxis Of Nausea And Vomiting 1.9%
Rectal Cancer 1.8%
Anaemia 1.7%
Sepsis 11.6%
Vomiting 10.1%
Interstitial Lung Disease 9.7%
Pulmonary Embolism 7.9%
Renal Failure 6.3%
White Blood Cell Count Decreased 6.3%
Thrombocytopenia 6.0%
Pyrexia 5.0%
Renal Failure Acute 5.0%
Septic Shock 3.5%
Ascites 3.1%
Ileus Paralytic 3.1%
Stomatitis 3.1%
Acute Respiratory Failure 2.8%
Decreased Appetite 2.8%
Nausea 2.8%
Platelet Count Decreased 2.8%
Spinal Compression Fracture 2.8%
Peripheral Sensory Neuropathy 2.5%
Pneumopericardium 2.5%
Concomitant
Rectal Cancer Metastatic 9.4%
Gastric Cancer 8.9%
Drug Use For Unknown Indication 7.9%
Cancer Pain 6.8%
Diagnostic Procedure 6.3%
Prophylaxis 5.9%
Gastritis Atrophic 5.4%
Colon Cancer 5.0%
Prophylaxis Of Nausea And Vomiting 4.8%
Colon Cancer Metastatic 4.5%
Angle Closure Glaucoma 4.0%
Large Intestine Carcinoma 3.9%
Colon Cancer Recurrent 3.7%
Hypertension 3.7%
Rectal Cancer Recurrent 3.6%
Diarrhoea 3.5%
Premedication 3.5%
Rectal Cancer 3.5%
Lung Neoplasm Malignant 2.9%
Pain 2.8%
Interstitial Lung Disease 15.1%
Pyrexia 13.8%
Septic Shock 8.8%
Renal Impairment 6.9%
Shock 4.4%
Cerebral Infarction 3.8%
Loss Of Consciousness 3.8%
Metastases To Liver 3.8%
Neuropathy Peripheral 3.8%
Neutropenia 3.8%
Neutrophilia 3.8%
Somnolence 3.8%
Spinal Disorder 3.8%
White Blood Cell Count Decreased 3.8%
Asthma 3.1%
Pulmonary Embolism 3.1%
Vomiting 3.1%
Ascites 2.5%
Cholangitis Sclerosing 2.5%
Death 2.5%
Interacting
Gastric Cancer 40.0%
Constipation 20.0%
Gastrooesophageal Reflux Prophylaxis 20.0%
Prophylaxis Of Nausea And Vomiting 15.0%
Pyrexia 5.0%
Drug Interaction 100.0%